Neurocrine Clinical Site

Leawood, Kansas 66206

We've found

1 trials

at this facility

Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Leawood, KS

Use our guide to learn which trials are right for you!